by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme
by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme
by Sujith Ramachandran, Adam Pate,The ConversationCredit: Unsplash/CC0 Public DomainEven when Americans have health insurance, they can have a hard timeaffording the drugs they've been prescribed.
by Sujith Ramachandran, Adam Pate,The ConversationCredit: Unsplash/CC0 Public DomainEven when Americans have health insurance, they can have a hard timeaffording the drugs they've been prescribed.